Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
As the end of the year approaches, so does the annual...
Abcam, a UK maker of protein research tools, will pay...
Forward-thinking industry executives converged upon...
Shenogen Pharma of Beijing raised $20 million in a Series...
Mindray Medical, the Shenzhen medical device maker,...
Ascentage Pharma, an innovative small-molecule oncology...
DaVita Healthcare, a US owner/operator of dialysis...
Simcere Pharma, a Nanjing company that makes branded...
WuXi PharmaTech, China's largest CRO/CMO, is planning to...
San Diego's Sorrento Therapeutics has signed a binding...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
